Botanical species · safety record

Bombax ceiba

The EFSA Compendium of Botanicals holds 8 constituent measurements and 3 adverse-effect records for Bombax ceiba. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Bombax ceiba L.

8Constituent measurements

3Safety records

5Cited sources

9Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 9 licensed products naming Bombax ceiba as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aged bark
Flower
Gum
Gum (standardized extract)
Gum oleoresin
Stem bark
Stem bark extract

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Bombalin	Flower	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Bombasin	Flower	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Esculetin	Flower	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Fraxetin	Flower	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Limettin	Leaves	Solvent extraction	—	—	No resolvable identifier
Neolignans	Flower	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Scopoletin	Flower	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Scopolin	Flower	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Hepatotoxicity	Liver	Bark	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI
Neurotoxicity	Neurologic: central nervous system	Leaves	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI
Not stated	Urogenital: kidneys	Leaves	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Joshi, Khem Raj., Devkota, Hari Prasad., Yahara, Shoji. Chemical Analysis of Flowers of Bombax ceiba from Nepal. NATURAL PRODUCT COMMUNICATIONS, 2013, vol. 8, no. 5, p. 583-584.
Wang, Guo-kai., Lin, Bin-bin., Liu, Xin-xin., Shen, Ya-jun., Qin, Min-jian. Phonemic constituents from the leaves of Bombax malabaricum. Tianran chanwu yanjiu yu kaifa, 2012, p. 336-338.
Wu, Jun., Zhang, Xiao-Hui., Zhang, Shu-Wei., Xuan, Li-Jiang. Three novel compounds from the flowers of Bombax malabaricum. Helvetica Chimica Acta, 2008, p. 136-143.
Saleem, R., Ahmad, M., Hussain, SA., Qazi, AM., Ahmad, SI., Qazi, MH., Ali, M., Faizi, S., Akhtar, S., Husnain, SN. Hypotensive, hypoglycaemic and toxicological studies on the flavonol C-glycoside shamimin from Bombax ceiba. PLANTA MEDICA, 1999, vol. 65, no. 4, p. 331-334. DOI
Saleem, R., Ahmad, SI., Ahmed, M., Faizi, Z., Zikr-ur-Rehman, S., Ali, M., Faizi, S. Hypotensive activity and toxicology of constituents from Bombax ceiba stem bark. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, vol. 26, no. 1, p. 41-46. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature